New medical device vigilance guidelines take effect in Egypt

01/7/2013 | Clinica (subscription required)

The Egyptian Drug Authority has finalized guidelines governing its medical device vigilance program, which details responsibilities for the agency's Medical Device Safety Department, device users and manufacturers. The guidance took effect on Jan. 1 and includes changes to a draft version released in 2011, including a new section on in vitro diagnostics.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ